Which fecal occult blood test is best to screen for colorectal cancer?

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 6, Issue 3, 2009, Pages 140-141

  Young, Graeme P ^a   Cole, Stephen R ^b  

^a FLINDERS UNIVERSITY   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIET RESTRICTION; FALSE POSITIVE RESULT; FECES ANALYSIS; FOLLOW UP; HUMAN; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; NOTE; OCCULT BLOOD TEST; PATIENT PARTICIPATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY;

EID: 62549083409     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1358     Document Type: Note

References (6)

1. Allison JE et al. (1996) A comparison of fecal occult-blood tests for colorectal cancer screening. N Engl J Med 334: 155-159
2. Young GP and Allison J (2008) Screening for colorectal cancer. In Textbook of Gastroenterology, edn 5 170-182 (Eds Yamada T et al. Philadelphia: Lippincott Williams and Wilkins
3. Smith A et al. (2006) Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer 107: 2152-2159
4. Van Rossum LG et al. (2008) Random comparison of guaiac and immunochemical fecal occult blood test for colorectal cancer in a screening population. Gastroenterology 135: 82-90
5. Nakajima M et al. (2003) Prevention of advanced colorectal cancer by screening using the immunochemical faecal occult blood test: A case-control study. Br J Cancer 89: 23-28
6. Cole SR et al. (2003) A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 10: 117-122